Carl Sandler's most recent trade in Renovaro Biosciences Inc was a trade of 3,969,090 Common Stock done . Disclosure was reported to the exchange on April 15, 2022.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Renovaro Biosciences Inc | Carl Sandler | Former director see note below | Other type of transaction at price $ 0.00 per share. | 15 Apr 2022 | 3,969,090 | 3,456,831 (7%) | 8% | 0 | Common Stock | |
| Renovaro Biosciences Inc | Carl Sandler | Former director see note below | Other type of transaction at price $ 0.00 per share. | 15 Apr 2022 | 992,273 | 4,449,104 (9%) | 2% | 0 | Common Stock | |
| Renovaro Biosciences Inc | Carl Sandler | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 9.06 per share. | 22 Mar 2022 | 1,927 | 3,187,487 (6%) | 0% | 9.1 | 17,459 | Common Stock |
| Renovaro Biosciences Inc | Carl Sandler | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 9.03 per share. | 18 Feb 2022 | 6,792 | 3,189,420 (6%) | 0% | 9.0 | 61,348 | Common Stock |
| Renovaro Biosciences Inc | Carl Sandler | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 9.00 per share. | 18 Feb 2022 | 6 | 3,189,414 (6%) | 0% | 9 | 54 | Common Stock |
| Renovaro Biosciences Inc | Carl Sandler | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2021 | 12,712 | 12,712 | - | - | Option to purchase shares of common stock | |
| Renovaro Biosciences Inc | Carl Sandler | Director, Ten Percent Owner | Other type of transaction at price $ 0.00 per share. | 14 Dec 2020 | 61,249 | 4,961,363 (10%) | 0% | 0 | Common Stock |